Cardiomyopathies conferences
The second edition of the Masterclass on Hypertrophic Obstructive Cardiomyopathy was held in Florence from November 11 to 13, 2025. Thirty speakers and over 150 cardiologists from across Italy participated.
The second edition of the Masterclass on Hypertrophic Obstructive Cardiomyopathy will be held in Florence from November 11 to 13, 2025. The event, sponsored by AICARM APS and organized by Professor Iacopo Olivotto, will bring together national and international experts to delve deeper into diagnosis, genetics, imaging, and new therapeutic strategies.
The Ragusa days demonstrated the power of direct contact between patients, doctors, and families. Participatory courses, shared experiences, and a successful format for building a conscious and supportive community.
The Masterclass held in Florence in November provided a valuable opportunity to disseminate, update, and discuss the state of the art in hypertrophic obstructive cardiomyopathy, with an eye toward future prospects.
AICARM announces its sponsorship of the Masterclass on Hypertrophic Obstructive Cardiomyopathy to be held in Florence on November 26-27, 2024. The course offers an update on the pathophysiology, diagnosis, and treatment of hypertrophic cardiomyopathy.
AICARM announces its patronage of the "Roma Cardiomyopathies" congress on 18-19 October 2024 in Rome, aimed at strengthening collaboration between cardiologies in the management of heart muscle diseases and rare diseases. The event promotes the exchange of experiences between Italian cardiology schools, supporting professional growth and the creation of a network. AICARM invites cardiologists and specialists to participate.
The course aims to provide a comprehensive and updated overview of the pathophysiology, diagnostics and treatment of patients with cardiomyopathies, with the precious contribution of experts operating in prestigious national institutions. The topics covered are extremely broad and new, from genetic diagnosis to new pharmacological and gene therapy perspectives. Clinical cases will be presented, with discussion of the different possible options in the decision making process, with the evaluation of the ECG, echocardiogram, cardiac MRI, and more complex invasive tests. up to the interpretation of the genetic analysis. All teaching staff have specific experience in the sector.
The II MASTERCLASS - HYPERTROPHIC CARDIOMYOPATHY AND CARDIAC AMYLOIDOSIS will be held in Florence on June 8th and 9th, under the patronage of AICARM Onlus.
On 13 April 2023 AICARM, at the request of the organizers of the congress "Advances in pediatric heart failure: congenital heart disease and cardiomyopathies", underway in Florence, hosted a meeting dedicated to the new perspectives for the use of "gene therapy for the treatment of cardiomyopathies.
